Europe
At the Annual General Meeting of Immunicum AB (publ), reg. no 556629-1786, on April 25, 2019 the AGM adopted, inter alia, the following resolutions.
David Wilkinson brings experience of strategy & governance in growth firms
Conference call to be held today, 25 April 2019, 3:00pm CET/2:00pm BST
Companies strengthen leadership teams with C-suite and boards of directors appointments, with new hires at Sandoz, Mission Bio, SkinBio, Epic Sciences, and more.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
The funding will be used to expand the production capacity of key components of the adjuvant system used in several of GSK’s vaccines, including shingles vaccine, Shingrix.
The project company Belina is running an innovative project in early phase and is developing a product for treatment of breast cancer.
Pharnext SA announced its financial results for the fiscal year ended December 31st, 2018.
Turf cutting for the Bellhouse Building to be performed by Lord & Lady Drayson
Biom’up announced that the U.S. Food and Drug Administration approved the IDE application for HEMOSNOW, a hemostatic dry powder made from porcine collagen and bovine-derived chondroitin sulfate developed by the Company for managing minimal and mild levels of bleeding during surgical procedures.
PRESS RELEASES